Published 2y ago - MICHAEL J. MANGANO
by MICHAEL J. MANGANO Since U.S. pharmaceutical companies have recently been plagued by rising R&D, advertising and administrative costs, as well as shrinking profits from sales to foreign markets, – not to mention the President’s recent declaration to... More »